Otoflu Eye/Ear Drops contain Fluconazole 0.3% w/v, an antifungal agent effective against a broad spectrum of fungal infections affecting the eyes and ears. Fluconazole belongs to the triazole class of antifungals and works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting fungal cell integrity and leading to cell death. Otoflu Eye/Ear Drops are indicated for the treatment of superficial fungal infections such as otomycosis and fungal conjunctivitis caused by susceptible Candida and Aspergillus species. The formulation is designed for topical application, ensuring localized delivery with minimal systemic absorption, which reduces the risk of systemic side effects. Prior to administration, the affected area should be cleaned and dried thoroughly. The recommended dosage is typically one to two drops instilled into the affected eye or ear two to three times daily, or as directed by a healthcare professional. Patients should avoid contaminating the dropper tip to prevent secondary infections. Use during pregnancy and lactation should be under medical supervision. Adverse effects are generally mild and may include transient burning, irritation, or redness at the application site. Otoflu Eye/Ear Drops should be stored at room temperature, protected from light, and kept out of reach of children.